SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-229851
Filing Date
2017-07-18
Accepted
2017-07-18 08:47:02
Documents
4
Period of Report
2017-07-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d425893d8k.htm 8-K 26474
2 EX-99.1 d425893dex991.htm EX-99.1 17312
3 GRAPHIC g425893g44t96.gif GRAPHIC 3335
4 GRAPHIC g425893g53j96.gif GRAPHIC 2484
  Complete submission text file 0001193125-17-229851.txt   53047
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 17968566
SIC: 2834 Pharmaceutical Preparations